RecruitingNCT06401304

Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)

Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery. A Multicentre, Cohort Study


Sponsor

Uppsala University

Enrollment

1,200 participants

Start Date

Jan 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The study aspires to provide outcomes on surgery, quality of life and time-to-event outcomes following the development and validation of a standardised surgical assessment tool in a shared decision-making framework for patients with pre-invasive or invasive breast cancer with breast conservation.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria4

  • Female aged above 18 years.
  • Signed and dated written informed consent before the start of specific protocol procedures; oral consent for the participants of the quality control retrospective cohort study before accepting to partake a telephone interview.
  • Patients with invasive breast cancer (IBC) or ductal cancer in situ (DCIS) or unclear lesions mandating surgical excision or benign lesions amenable for surgical resection with BCS.
  • ECOG performance status 0-2.

Exclusion Criteria3

  • Life expectancy of less than 6 months
  • Non candidate for breast conservation
  • Inability to understand given information and give informed consent or undergo study procedures

Locations(3)

Westmead Breast Cancer Institute

Sydney, Australia

Uppsala University Hospital

Uppsala, Sweden

Royal Marsden Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06401304


Related Trials